We also demonstrated that the inhibition of active JNK and its downstream Nrf2 and NF-κB signaling through a specific JNK inhibitor SP600125 might alleviate neuronal apoptosis, neuroinflammation, and memory disorders in a model of unilateral cerebral ischemia. Here, NFE2L2 is linked to brain ischemia.